Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Role of GLP-1 Agonists and SGLT-2 on Diabetes and Kidney Disease Post Liver Transplant The emergence of Glucagon-like peptide-1 receptor (GLP-1) agonists and Sodium-glucose cotransporter-2 (SGLT-2) inhibitors as glucose-lowering therapies has opened new therapeutic avenues for managing patients with diabetic kidney disease
17.7% CAGR, driven by provincial delivery and benefit variation
Contact us at [email protected] if you see an error.
doi: 10.1159/000506879CrossRefGoogle ScholarPubMed Chanson, P., Arnoux, A., Mavromati, M., Brailly-Tabard, S., Massart, C., Young, & J., for the VARIETE Investigators (2016)
US$ 23.56
US$ 23.42
US$ 25.96
US$ 20.45
US$ 21.69
![Fumiko the Lowblood [Commander Anthology Volume II] SPA Catacumba inundada](https://cdn.shopify.com/s/files/1/0268/5285/1798/products/32625c5d-6e62-4bbb-bd8d-d752090585ea.jpg?v=1571890237)